Study guide
7.3 Valvular Heart Disease & Murmur Interpretation
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
7.3 Valvular Heart Disease & Murmur Interpretation
Key Takeaways Explain This Topic AI
Symptomatic severe aortic stenosis (valve area below 1 cm2, mean gradient above 40 mmHg) is an indication for valve replacement; a slow-rising pulse and quiet second heart sound suggest severity.
Severe aortic regurgitation gives a collapsing pulse, wide pulse pressure and an early diastolic murmur, with surgery indicated once the left ventricular end-systolic diameter exceeds 50 mm or the ejection fraction falls below 50%.
Hypertrophic cardiomyopathy murmurs increase with Valsalva and standing, whereas aortic stenosis murmurs decrease - the key bedside discriminator.
Last updated: September 2026
Valvular heart disease and infective endocarditis are core pillars of cardiovascular examination and therapeutics in MRCP(UK) Part 1. Candidates must recognize classic hemodynamic profiles, eponymous physical examination signs, echocardiographic grading thresholds, diagnostic criteria, and indications for surgical intervention.
- 1. Aortic Stenosis (AS)
- Pathophysiology & Aetiology
Aortic stenosis is the most prevalent primary valvular lesion in the UK and Western nations. The primary aetiologies include:
Calcific Degeneration: Age-related dystrophic calcification and progressive fibrocalcific remodelling of a trileaflet aortic valve, typically manifesting in patients >70 years.
Congenital Bicuspid Aortic Valve (BAV): Affects 1–2% of the population. Accelerated shear stress causes valve calcification and stenosis manifesting significantly earlier (40–60 years). Strongly associated with ascending aortic aneurysm, aortic coarctation, and aortic dissection.
Rheumatic Heart Disease: Characterized by commissural fusion, leaflet thickening, and concurrent mitral valve involvement; now rare in the UK but prevalent in developing nations.
Progressive outflow obstruction causes compensatory concentric left ventricular hypertrophy (LVH) to normalize wall stress (Laplace's law: stress = pressure x radius / 2 x wall thickness). Over time, diastolic dysfunction develops, followed by subendocardial ischaemia, myocyte apoptosis, left ventricular dilatation, and systolic heart failure.
Clinical Presentation & Cardinal Symptoms
Asymptomatic AS carries a relatively low risk of sudden cardiac death (<1% per year). However, the onset of cardinal symptoms marks a dramatic transition in prognosis:
Angina Pectoris (Average survival ~5 years without valve replacement): Driven by increased myocardial oxygen demand (hypertrophied LV and high systolic wall stress) alongside decreased oxygen supply (compression of subendocardial coronary arterioles and reduced coronary perfusion pressure).
Syncope / Presyncope (Average survival ~3 years): Typically exertional. Caused by an inability to augment cardiac output across the fixed, stenotic orifice during exercise, combined with peripheral vasodilation and exercise-induced ventricular mechanoreceptor reflexes (Bezold-Jarisch reflex) triggering sudden bradycardia and vasodepression.
Dyspnoea / Heart Failure (Average survival ~2 years): Reflects elevated left ventricular end-diastolic pressure transmitting retrogradely into pulmonary capillaries.
Physical Examination Signs
Arterial Pulse: Pulsus parvus et tardus (slow-rising, low-amplitude carotid pulse with a delayed peak). Narrow pulse pressure (e.g., 105/85 mmHg).
Precordial Palpation: Heaving, sustained, non-displaced apex beat (concentric LVH). Palpable systolic thrill over the second right intercostal space.
Auscultation:
Murmur: Harsh, crescendo-decrescendo ejection systolic murmur , loudest at the second right intercostal space, radiating characteristically to both carotid arteries. Murmur intensity peaks later in systole as stenosis worsens.
Second Heart Sound (S2): Soft or inaudible aortic closure sound (A2) due to rigid, calcified leaflets. Paradoxical (reversed) splitting of S2 occurs because prolonged LV ejection delays A2 until after pulmonic valve closure (P2); consequently, splitting narrows during inspiration and widens during expiration.
Fourth Heart Sound (S4): Frequently present, reflecting vigorous left atrial contraction into a non-compliant, stiff hypertrophied LV.
Echocardiographic Severity Criteria & Management
Transthoracic echocardiography is the gold standard diagnostic investigation:
- Severity Grading Aortic Valve Area (AVA) Mean Transvalvular Gradient Peak Aortic Jet Velocity (Vmax)
- Mild AS >1.5 cm² <25 mmHg <3.0 m/s
- Moderate AS 1.0–1.5 cm² 25–40 mmHg 3.0–4.0 m/s
- Severe AS <1.0 cm² (or <0.6 cm²/m² BSA) >40 mmHg >4.0 m/s
Indications for Valve Intervention:
All symptomatic patients with severe AS .
Asymptomatic patients with severe AS who have:
Impaired left ventricular systolic function (LVEF <50%) without other identifiable cause.
Symptoms unmasked on supervised exercise testing (or an abnormal fall in blood pressure >10 mmHg during exercise).
Very severe AS defined by peak velocity >5.0 m/s or mean gradient >60 mmHg.
Intervention Modality (Heart Team Decision):
Surgical Aortic Valve Replacement (SAVR): Preferred in patients <75 years of age with low surgical risk (STS/EuroSCORE II <4%) or those undergoing concurrent CABG/aortic root surgery. Mechanical valves are favored in patients <60 years (require lifelong warfarin with INR target 2.0–3.0 depending on risk factors); bioprosthetic valves are used in older patients (do not require lifelong anticoagulation, but degenerate over 10–15 years).
Transcatheter Aortic Valve Implantation (TAVI): Preferred in patients >=75 years, those with high or prohibitive surgical risk, severe frailty, or a porcelain aorta.
- 2. Aortic Regurgitation (AR)
- Pathophysiology & Aetiology
Aortic regurgitation results from leaflet incompetence or aortic root dilatation:
Valvular Causes: Infective endocarditis, congenital bicuspid valve, rheumatic heart disease, trauma.
Aortic Root Causes: Ascending aortic aneurysm, Stanford Type A aortic dissection, connective tissue disorders (Marfan syndrome, Loeys-Dietz, Ehlers-Danlos), systemic hypertension, syphilitic aortitis, and seronegative spondyloarthropathies (ankylosing spondylitis).
In chronic AR, diastolic regurgitation into the left ventricle induces combined volume and pressure overload, triggering eccentric left ventricular hypertrophy and massive ventricular dilatation ("cor bovinum").
Physical Examination & Eponymous Signs
Pulse & Hemodynamics: Collapsing pulse ("water-hammer" or Corrigan's pulse )—rapid distension with abrupt collapse. Wide pulse pressure (e.g., 170/45 mmHg) resulting from elevated systolic stroke volume and rapid diastolic run-off into both the peripheral circulation and back into the left ventricle.
Apex Beat: Displaced inferolaterally, hyperdynamic, and thrusting.
Auscultation:
High-pitched, blowing early diastolic decrescendo murmur , best appreciated at the left lower sternal border (3rd/4th intercostal space) with the patient sitting forward, in held end-expiration.
Systolic flow murmur across the aortic valve due to massive forward stroke volume.
Austin Flint Murmur: Low-pitched, rumbling mid-diastolic apical murmur caused by the regurgitant aortic jet striking and vibrating the anterior mitral valve leaflet, creating functional mitral stenosis.
Classic Eponymous Peripheral Signs:
Quincke's Sign: Capillary pulsations visible in the nail beds upon gentle compression.
de Musset's Sign: Rhythmic nodding of the head in synchrony with cardiac systole.
Duroziez's Sign: Double murmur auscultated over the femoral artery (systolic murmur with proximal compression, diastolic murmur with distal compression).
Traube's Sign: Booming "pistol shot" sounds heard over the femoral arteries during systole.
Müller's Sign: Systolic pulsation of the uvula.
Management
Surgical aortic valve replacement is indicated in all symptomatic severe AR patients, and in asymptomatic patients with resting LVEF <=50% or progressive left ventricular dilatation (LV end-systolic diameter >50 mm or >25 mm/m² BSA).
- 3. Mitral Valve Disease
- Mitral Stenosis (MS)
Aetiology: Rheumatic fever accounts for >95% of cases worldwide. Fibrotic leaflet thickening, commissural fusion, and chordal shortening produce a "fish-mouth" or "funnel-shaped" orifice.
Hemodynamics: Fixed mechanical obstruction to left ventricular filling elevates left atrial pressure, causing left atrial enlargement, pulmonary venous hypertension, reactive pulmonary arteriolar vasoconstriction, and secondary right-sided heart failure.
Physical Signs:
Malar Flush: Plum-coloured purplish patch over the malar prominences, secondary to cutaneous vasodilation and chronic low cardiac output.
Apex Beat: Tapping apex beat (representing a palpable, loud first heart sound without cardiomegaly; the apex beat is not displaced).
Auscultation: Loud S1 (pliable leaflets snap shut under elevated LA pressure); Opening Snap (OS) (high-frequency early diastolic sound caused by sudden arrest of doming stenotic leaflets). The interval between A2 and the opening snap inversely correlates with severity (narrow A2–OS interval denotes more severe stenosis). Followed by a low-pitched, rumbling mid-diastolic murmur best heard with the stethoscope bell at the apex in the left lateral decubitus position, terminating with presystolic accentuation (lost when atrial fibrillation supervenes).
Complications: Thromboembolism (stroke in 20%), hemoptysis (rupture of bronchial veins/pulmonary apoplexy), and Ortner's syndrome (hoarseness caused by compression of the left recurrent laryngeal nerve between the enlarged left atrium and the pulmonary artery).
Intervention: Percutaneous Mitral Balloon Commissurotomy (PMBC) is the procedure of choice if the valve morphology is pliable and free of heavy calcification (Wilkins echocardiographic score <=8) without left atrial thrombus or moderate-to-severe MR.
Mitral Regurgitation (MR)
Aetiology: Degenerative/Myxomatous (mitral valve prolapse—presents with a mid-systolic click and late systolic murmur), ischaemic (papillary muscle dysfunction or acute rupture, classically the posteromedial papillary muscle following RCA inferior MI), functional (LV dilatation in cardiomyopathy), infective endocarditis, or rheumatic.
Physical Signs: Hyperdynamic, laterally displaced apex beat; blowing pansystolic (holosystolic) murmur loudest at the apex, radiating into the left axilla; soft S1; prominent third heart sound (S3) reflecting high-volume, rapid diastolic filling of the left ventricle.
4. Physical Examination & Murmur Summary Table
Lesion Pulse Characteristic Apex Beat S1 / S2 Findings Murmur Timing & Characteristics Radiation & Manoeuvres
Aortic Stenosis Pulsus parvus et tardus; narrow pulse pressure Heaving, non-displaced Soft/absent A2; paradoxical split S2; S4 gallop Harsh ejection systolic; crescendo-decrescendo Radiates to carotids; louder on expiration and squatting
Aortic Regurgitation Collapsing (Corrigan's); wide pulse pressure Displaced, hyperdynamic Soft S1; S3 gallop in decompensation High-pitched early diastolic decrescendo; Austin Flint mid-diastolic rumble Left sternal edge; louder sitting forward in held expiration
Mitral Stenosis Small volume; regular or irregularly irregular (AF) Tapping (palpable S1); non-displaced Loud S1; Opening Snap (narrow A2–OS = severe) Low-pitched, rumbling mid-diastolic with presystolic accentuation Localized to apex; louder in left lateral position with bell in expiration
Mitral Regurgitation Normal or brisk pulse Hyperdynamic, displaced inferolaterally Soft S1; loud P2 if pulmonary HTN; prominent S3 High-pitched, blowing pansystolic (holosystolic) Radiates to axilla; louder on expiration and handgrip (increased afterload)